Theranos 'voids TWO YEARS of blood tests' as firm admits it misdiagnosed tens of thousands of patients
The firm won $9 billion valuation in 2014 after claiming its Edison machines could detect multiple diseases from just one drop of blood.
Theranos 'voids TWO YEARS of blood tests' as firm admits it misdiagnosed tens of thousands of patients